CLINICAL ROLE -
Air Pollution Raises Risk of Cardiovascular Disease
High exposure to fine particulate matter found to increase biomarkers for inflammation and oxidative stress.
Read More
Immunotherapy May Lead to Cure for Type 1 Diabetes
It may be possible to retrain the immune system to prevent or slow attacks on insulin-producing beta cells.
Opioid Use for Pain Management Higher Among Cancer Survivors
Study finds greater rate of opioid prescribing among cancer survivors 10 or more years past their cancer diagnosis.
Alerts Increase Hepatitis C Screening Among Baby Boomers
Baby boomer hepatitis C virus screening rates spiked when a prompt in their electronic health records reminded a primary care provider to recommend testing.
FDA Approves Generic Depressive Disorder Drug
Cymbalta is also indicated to treat general anxiety disorder in adults and children, fibromyalgia, or chronic muscle or joint pain, such as low back pain and osteoarthritis.
10 Signs You Have the Wrong Pharmacy Job (And What You Can Do About It)
Everyone should be looking for new opportunities and great prospects.
PharmD WorldWide: Serving as a Pharmacist Missionary
Have you ever thought about serving as a pharmacist on a medical mission trip?
4 Tips to Use After Graduation
After graduation, the pressure was on.
Could a Text Messaging System Be the Answer to Adherence Issues?
According to the American Diabetes Association a two-way text messaging system maybe the answer, as this method has shown to either maintain or lower glycemic control.
FDA Approves Generic Cymbalta Capsules
Top 5 Highest-Selling Drugs of 2016
Specialty drugs represent highest grossing prescription drugs of 2016.
Utilizing Medication Aids to Improve Adherence in Transplant Patients
Patients who have received a transplant and are non-adherent to their medication regimens are more likely to experience graft failure and higher health care costs.
Majority of Americans Believe Flu Vaccine is Effective
Approximately 65% of Americans would go to work if they were presenting flu-like symptoms.
FDA Accepts Review of Biologics License Application Resubmission Bleeding Event Treatment
Andexanet alfa is the first compound being investigated as an antidote for Factor Xa inhibitors.
Epilepsy Rates on the Rise in the United States
Epilepsy prevalence increased by 700,000 between 2010 and 2015.
Chronic Inflammation in Rheumatoid Arthritis Attributed to Hibernating Cells
Hibernating innate lymphoid cells allows inflammation to persist in rheumatoid arthritis.
Atrial Fibrillation Risk Increases with Reduced Kidney Function
Patients with poor kidney function may have a 2-fold increase in atrial fibrillation.
Trending News Today: Ovarian Cancer Patient Awarded $417 Million in J&J Baby Powder Lawsuit
Top news of the day from across the health care landscape.
Trending News Today: China Serves as an Ally in Fight Against Opioids
Top news of the day from across the healthcare landscape.
Exploring the Role of Citrate Transport Pathway in Liver Cancer Growth
Understudied gene provides insight into how liver cancer cells gain the nutrition necessary to proliferate.
Experimental Class of Breast Cancer Drugs Inhibit Recurrent Disease
A first-in-class molecule was found to inhibit primary and recurrent breast cancer.
Cost of Pharmaceuticals in the Long Run
Corticosteroids Create Challenges in Severe Asthma Treatment
The cost and adverse events associated with corticosteroids need to be considered for patients with severe asthma.
Treating Young HIV Patients Has Different Set of Challenges
Younger patients with HIV have competing needs that distract them from fully engaging in care.
FDA Approves Novel Fixed-Dose Combo Treatment for Gout
The FDA has approved a new fixed-dose combination treatment for hyperuricemia in patients with uncontrolled gout.
Get the Dirt on DIR Fees
Direct and indirect remuneration fees can cause pharmacies to spend more on stocking and dispensing medications.
Multiple Sclerosis Drug Costs Called into Question
Legislative investigation seeks information from 7 drug makers on costs for MS medications.
Biosimilar of Humalog Shows Non-Inferiority in Type 1 Diabetes
Novel diabetes biosimilar shows similar safety, efficacy, and immunogenicity to the reference drug.
Gabapentinoids Ineffective for Low Back Pain
Gabapentin not found to improve low back pain more than a placebo.
FDA Accepts Supplemental Biologics License Application for Lymphoma Drug
Brentuximab vedotin under evaluation for the treatment of cutaneous T-cell lymphoma.